Participation
Contrave® and Empatic™ are still being evaluated in clinical trials and have not been approved for sale.
A Phase IIb clinical trial for Empatic is currently enrolling. Please refer to www.clinicaltrials.gov for information. Orexigen® cannot accept inquiries from individual patients.
Information will be posted here when new trials begin. Additional information about clinical trials for obesity is also available at www.clinicaltrials.gov
FOR PHYSICIANS: If you are a health care provider interested in learning more about our clinical trials, please send an email correspondence to clinicaltrials@orexigen.com.
FOR PATIENTS: To maintain patient privacy we are not permitted to accept correspondence from individuals. If you are interested in participating in a future trial, please have your personal physician send an email correspondence to clinicaltrials@orexigen.com.